Canada markets close in 31 minutes

Barinthus Biotherapeutics plc (BRNS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.2938-0.0362 (-1.57%)
As of 03:17PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 90.37M
Enterprise Value -38.74M
Trailing P/E 6.97
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)111.04
Price/Book (mrq)0.48
Enterprise Value/Revenue -2.12
Enterprise Value/EBITDA -18.29

Trading Information

Stock Price History

Beta (5Y Monthly) -0.44
52-Week Change 3-2.52%
S&P500 52-Week Change 326.16%
52 Week High 35.1000
52 Week Low 31.6400
50-Day Moving Average 32.5877
200-Day Moving Average 32.8065

Share Statistics

Avg Vol (3 month) 324.41k
Avg Vol (10 day) 37.39k
Shares Outstanding 538.95M
Implied Shares Outstanding 639.37M
Float 827.17M
% Held by Insiders 13.69%
% Held by Institutions 147.85%
Shares Short (Apr 30, 2024) 419.02k
Short Ratio (Apr 30, 2024) 40.52
Short % of Float (Apr 30, 2024) 40.08%
Short % of Shares Outstanding (Apr 30, 2024) 40.05%
Shares Short (prior month Mar 28, 2024) 410.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-10,024.69%

Management Effectiveness

Return on Assets (ttm)-20.73%
Return on Equity (ttm)-34.15%

Income Statement

Revenue (ttm)802k
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -78.17M
Net Income Avi to Common (ttm)-73.35M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.09M
Total Cash Per Share (mrq)3.65
Total Debt (mrq)12.98M
Total Debt/Equity (mrq)6.94%
Current Ratio (mrq)12.45
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-50.92M
Levered Free Cash Flow (ttm)-42.35M